| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
|
J Clin Endocrinol Metab
|
2003
|
4.93
|
|
2
|
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.
|
J Clin Endocrinol Metab
|
2008
|
3.38
|
|
3
|
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
|
J Clin Endocrinol Metab
|
2007
|
2.74
|
|
4
|
Retracted
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.
|
J Clin Invest
|
2005
|
2.09
|
|
5
|
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2007
|
1.95
|
|
6
|
Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
|
J Clin Endocrinol Metab
|
2004
|
1.82
|
|
7
|
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
|
Ann Thorac Surg
|
2005
|
1.75
|
|
8
|
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
|
J Clin Endocrinol Metab
|
2010
|
1.63
|
|
9
|
The BRAF(V600E) mutation is an independent, poor prognostic factor for the outcome of patients with low-risk intrathyroid papillary thyroid carcinoma: single-institution results from a large cohort study.
|
J Clin Endocrinol Metab
|
2012
|
1.62
|
|
10
|
Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2004
|
1.56
|
|
11
|
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma.
|
Cancer Res
|
2007
|
1.47
|
|
12
|
Surgical treatment of pleural recurrence from thymoma.
|
Eur J Cardiothorac Surg
|
2008
|
1.46
|
|
13
|
Low prevalence of the somatic M918T RET mutation in micro-medullary thyroid cancer.
|
Thyroid
|
2012
|
1.45
|
|
14
|
Osteopontin expression and prognostic significance in non-small cell lung cancer.
|
Clin Cancer Res
|
2005
|
1.35
|
|
15
|
RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
|
J Clin Endocrinol Metab
|
2007
|
1.31
|
|
16
|
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer.
|
Endocr Relat Cancer
|
2008
|
1.26
|
|
17
|
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
|
Clin Cancer Res
|
2004
|
1.25
|
|
18
|
The timing of total thyroidectomy in RET gene mutation carriers could be personalized and safely planned on the basis of serum calcitonin: 18 years experience at one single center.
|
J Clin Endocrinol Metab
|
2011
|
1.18
|
|
19
|
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer.
|
Cancer Res
|
2007
|
1.17
|
|
20
|
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
|
J Clin Endocrinol Metab
|
2005
|
1.17
|
|
21
|
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2007
|
1.16
|
|
22
|
Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.
|
J Proteome Res
|
2008
|
1.14
|
|
23
|
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas.
|
Oncogene
|
2004
|
1.14
|
|
24
|
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment.
|
Eur J Cardiothorac Surg
|
2009
|
1.12
|
|
25
|
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.
|
Cancer Res
|
2009
|
1.11
|
|
26
|
Minimally invasive video-assisted thyroidectomy: an analysis of results and a revision of indications.
|
Surg Endosc
|
2011
|
1.10
|
|
27
|
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
|
J Clin Endocrinol Metab
|
2012
|
1.08
|
|
28
|
Incidental thyroid carcinoma in a large series of consecutive patients operated on for benign thyroid disease.
|
ANZ J Surg
|
2006
|
1.07
|
|
29
|
WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
|
Clin Cancer Res
|
2007
|
1.06
|
|
30
|
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
|
J Clin Endocrinol Metab
|
2012
|
1.04
|
|
31
|
Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies.
|
J Clin Endocrinol Metab
|
2007
|
1.03
|
|
32
|
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.
|
Int J Cancer
|
2014
|
1.02
|
|
33
|
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
|
Thyroid
|
2012
|
1.00
|
|
34
|
Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up.
|
J Thorac Oncol
|
2006
|
0.99
|
|
35
|
Presence of BRAF V600E in very early stages of papillary thyroid carcinoma.
|
Thyroid
|
2007
|
0.98
|
|
36
|
Management of pleural recurrence after curative resection of thymoma.
|
J Thorac Cardiovasc Surg
|
2008
|
0.97
|
|
37
|
Italian consensus for the classification and reporting of thyroid cytology.
|
J Endocrinol Invest
|
2014
|
0.94
|
|
38
|
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
|
J Clin Endocrinol Metab
|
2011
|
0.94
|
|
39
|
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2).
|
J Clin Endocrinol Metab
|
2003
|
0.94
|
|
40
|
Papillary thyroid cancer: pathological parameters as prognostic factors in different classes of age.
|
Otolaryngol Head Neck Surg
|
2008
|
0.94
|
|
41
|
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer.
|
J Clin Endocrinol Metab
|
2013
|
0.93
|
|
42
|
Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
|
Oncogene
|
2004
|
0.92
|
|
43
|
Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma.
|
Thyroid
|
2007
|
0.92
|
|
44
|
Toward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of study.
|
J Proteome Res
|
2012
|
0.91
|
|
45
|
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.
|
J Clin Endocrinol Metab
|
2006
|
0.91
|
|
46
|
Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer.
|
J Clin Endocrinol Metab
|
2002
|
0.90
|
|
47
|
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2008
|
0.89
|
|
48
|
EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan.
|
Target Oncol
|
2013
|
0.88
|
|
49
|
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
|
Endocr Connect
|
2013
|
0.88
|
|
50
|
Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes.
|
BMC Microbiol
|
2005
|
0.88
|
|
51
|
Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma.
|
Eur J Cancer
|
2005
|
0.88
|
|
52
|
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease.
|
J Clin Endocrinol Metab
|
2014
|
0.88
|
|
53
|
CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas.
|
Mod Pathol
|
2011
|
0.87
|
|
54
|
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.
|
Thyroid
|
2010
|
0.87
|
|
55
|
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer.
|
Endocr Relat Cancer
|
2010
|
0.87
|
|
56
|
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
|
Endocr Relat Cancer
|
2012
|
0.87
|
|
57
|
Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
|
Pharmacol Res
|
2010
|
0.87
|
|
58
|
All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
|
J Clin Endocrinol Metab
|
2004
|
0.87
|
|
59
|
Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma.
|
J Clin Endocrinol Metab
|
2005
|
0.86
|
|
60
|
A proteomic approach to study parathyroid glands.
|
Mol Biosyst
|
2010
|
0.86
|
|
61
|
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
|
Lung Cancer
|
2005
|
0.86
|
|
62
|
Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
|
Thyroid
|
2003
|
0.85
|
|
63
|
Clinically unpredictable prognostic factors in the outcome of medullary thyroid cancer.
|
Endocr Relat Cancer
|
2007
|
0.85
|
|
64
|
Metabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based study.
|
Surgery
|
2012
|
0.85
|
|
65
|
Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.
|
J Clin Endocrinol Metab
|
2004
|
0.84
|
|
66
|
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior.
|
Thyroid
|
2004
|
0.83
|
|
67
|
Tumour necrosis factor-alpha: prognostic role and relationship with interleukin-8 and endothelin-1 in non-small cell lung cancer.
|
Int J Mol Med
|
2006
|
0.82
|
|
68
|
Medullary thyroid cancer secreting carbohydrate antigen 19-9 (Ca 19-9): a fatal case report.
|
J Clin Endocrinol Metab
|
2013
|
0.81
|
|
69
|
Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.
|
Cancer Cytopathol
|
2014
|
0.81
|
|
70
|
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
|
Clin Endocrinol (Oxf)
|
2008
|
0.81
|
|
71
|
Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters.
|
Thyroid
|
2011
|
0.81
|
|
72
|
Evaluation of the sensitivity to chemotherapeutics or thiazolidinediones of primary anaplastic thyroid cancer cells obtained by fine-needle aspiration.
|
Eur J Endocrinol
|
2008
|
0.81
|
|
73
|
Identification of targets of Twist1 transcription factor in thyroid cancer cells.
|
J Clin Endocrinol Metab
|
2014
|
0.80
|
|
74
|
A proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer.
|
Mol Biosyst
|
2012
|
0.80
|
|
75
|
Regulation of telomerase and its hTERT messenger in colorectal cancer.
|
Oncol Rep
|
2004
|
0.80
|
|
76
|
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
|
Virchows Arch
|
2015
|
0.80
|
|
77
|
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer.
|
Cytokine
|
2012
|
0.79
|
|
78
|
Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes.
|
J Clin Endocrinol Metab
|
2003
|
0.79
|
|
79
|
Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
|
J Clin Endocrinol Metab
|
2013
|
0.79
|
|
80
|
Intrathyroidal differentiated thyroid carcinoma: tumor size-based surgical concepts.
|
World J Surg
|
2007
|
0.79
|
|
81
|
Meningeal hemangiopericytoma metastatic to the adrenal gland with multiple metastases to bones and lungs: a case report.
|
Tumori
|
2004
|
0.79
|
|
82
|
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
|
Endocr Relat Cancer
|
2009
|
0.78
|
|
83
|
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
|
J Clin Endocrinol Metab
|
2013
|
0.78
|
|
84
|
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue.
|
Thyroid
|
2009
|
0.78
|
|
85
|
Chromosome 10 and RET gene copy number alterations in hereditary and sporadic Medullary Thyroid Carcinoma.
|
Mol Cell Endocrinol
|
2011
|
0.77
|
|
86
|
CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
|
Thyroid
|
2010
|
0.77
|
|
87
|
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer.
|
Hum Pathol
|
2004
|
0.77
|
|
88
|
Incidental versus clinically evident thyroid cancer: a 5-year follow-up study.
|
Head Neck
|
2012
|
0.77
|
|
89
|
Expression of endothelin 1 and its angiogenic role in meningiomas.
|
Virchows Arch
|
2006
|
0.77
|
|
90
|
Galectin-3 is highly expressed in nonencapsulated papillary thyroid carcinoma but weakly expressed in encapsulated type; comparison with Hector Battifora mesothelial cell 1 immunoreactivity.
|
Hum Pathol
|
2007
|
0.76
|
|
91
|
Prevalence of cancer in follicular thyroid nodules: is there still a role for intraoperative frozen section analysis?
|
Thyroid
|
2003
|
0.76
|
|
92
|
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis.
|
Tumori
|
2004
|
0.76
|
|
93
|
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung.
|
Lung Cancer
|
2013
|
0.76
|
|
94
|
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one.
|
PLoS One
|
2013
|
0.76
|
|
95
|
Prevalence of thyroid cancer in multinodular goiter versus single nodule: iodine intake and cancer phenotypes.
|
Thyroid
|
2014
|
0.75
|
|
96
|
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation.
|
J Cell Mol Med
|
2014
|
0.75
|
|
97
|
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer.
|
J Cutan Med Surg
|
2002
|
0.75
|
|
98
|
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells.
|
J Clin Invest
|
2016
|
0.75
|
|
99
|
A case of metastatic haemangiopericytoma to the thyroid gland: Case report and literature review.
|
Oncol Lett
|
2012
|
0.75
|
|
100
|
Proteomic approach used in the diagnosis of Riedel's thyroiditis: a case report.
|
J Med Case Rep
|
2012
|
0.75
|
|
101
|
Role of YAP-1 in Thyroid Tumor Progression and Outcome.
|
Appl Immunohistochem Mol Morphol
|
2016
|
0.75
|
|
102
|
FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.
|
Thyroid
|
2013
|
0.75
|
|
103
|
Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors.
|
Eur J Endocrinol
|
2004
|
0.75
|